Chronic myelogenous leukemia--identifying the hydra's heads
- PMID: 15306664
- DOI: 10.1056/NEJMp048120
Chronic myelogenous leukemia--identifying the hydra's heads
Comment on
-
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.N Engl J Med. 2004 Aug 12;351(7):657-67. doi: 10.1056/NEJMoa040258. N Engl J Med. 2004. PMID: 15306667
Similar articles
-
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.N Engl J Med. 2004 Aug 12;351(7):657-67. doi: 10.1056/NEJMoa040258. N Engl J Med. 2004. PMID: 15306667
-
New-age drug meets resistance.Nature. 2001 Jul 19;412(6844):281-2. doi: 10.1038/35085665. Nature. 2001. PMID: 11460142 No abstract available.
-
Cancer research. Proposed leukemia stem cell encounters a blast of scrutiny.Science. 2004 Aug 13;305(5686):929. doi: 10.1126/science.305.5686.929a. Science. 2004. PMID: 15310869 No abstract available.
-
Chronic myeloid leukemia--advances in biology and new approaches to treatment.N Engl J Med. 2003 Oct 9;349(15):1451-64. doi: 10.1056/NEJMra020777. N Engl J Med. 2003. PMID: 14534339 Review. No abstract available.
-
Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature.Leuk Res. 2009 Nov;33(11):e178-80. doi: 10.1016/j.leukres.2009.04.023. Epub 2009 May 14. Leuk Res. 2009. PMID: 19446330 Review. No abstract available.
Cited by
-
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.Cancer Chemother Pharmacol. 2012 Jun;69(6):1657-67. doi: 10.1007/s00280-012-1839-5. Epub 2012 Feb 15. Cancer Chemother Pharmacol. 2012. PMID: 22349810 Free PMC article. Clinical Trial.
-
Leukemia stem cells.Int J Hematol. 2006 Aug;84(2):123-7. doi: 10.1532/IJH97.A10503. Int J Hematol. 2006. PMID: 16926133 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous